AACR logo

More articles from Priority Brief

NKG7 Is Required for Optimal Antitumor T-cell Immunity
Xian-Yang Li, Dillon Corvino, Bianca Nowlan, Amelia Roman Aguilera, Susanna S. Ng, Matthias Braun, Anthony R. Cillo, Tobias Bald, Mark J. Smyth, Christian R. Engwerda

Cancer Immunology Research Jan 2022, DOI: 10.1158/2326-6066.CIR-20-0649
PBRM1 inactivation promotes upregulation of human endogenous retroviruses in a HIF-dependent manner
Mi Zhou, Janet Y Leung, Kathryn H Gessner, Austin J Hepperla, Jeremy M Simon, Ian J Davis, William Y Kim

Cancer Immunology Research Jan 2022, canimm.0480.2021; DOI: 10.1158/2326-6066.CIR-21-0480
Spatial UMAP and Image Cytometry for Topographic Immuno-oncology Biomarker Discovery
Nicolas A. Giraldo, Sneha Berry, Etienne Becht, Deniz Ates, Kara M. Schenk, Elizabeth L. Engle, Benjamin Green, Peter Nguyen, Abha Soni, Julie E. Stein, Farah Succaria, Aleksandra Ogurtsova, Haiying Xu, Raphael Gottardo, Robert A. Anders, Evan J. Lipson, Ludmila Danilova, Alexander S. Baras, Janis M. Taube

Cancer Immunology Research Nov 2021, 9 (11) 1262-1269; DOI: 10.1158/2326-6066.CIR-21-0015
CRASH-IT Switch Enables Reversible and Dose-Dependent Control of TCR and CAR T-cell Function
Ali Can Sahillioglu, Mireille Toebes, Georgi Apriamashvili, Raquel Gomez, Ton N. Schumacher

Cancer Immunology Research Sep 2021, 9 (9) 999-1007; DOI: 10.1158/2326-6066.CIR-21-0095
Regulatory T-cell Transcriptomic Reprogramming Characterizes Adverse Events by Checkpoint Inhibitors in Solid Tumors
Maria Grigoriou, Aggelos Banos, Aikaterini Hatzioannou, Andreas Kloetgen, Panagiotis Kouzis, Despoina Aggouraki, Roubini Zakopoulou, Giorgos Bamias, Eva Kassi, Dimitrios Mavroudis, Aristotelis Bamias, Dimitrios T. Boumpas, Aristotelis Tsirigos, Helen Gogas, Themis Alissafi, Panayotis Verginis

Cancer Immunology Research Jul 2021, 9 (7) 726-734; DOI: 10.1158/2326-6066.CIR-20-0969
Robust Antitumor Immunity in a Patient with Metastatic Colorectal Cancer Treated with Cytotoxic Regimens
Venkatesh Rajamanickam, Carmen Ballesteros-Merino, Kimberly Samson, David Ross, Brady Bernard, Bernard A. Fox, Eric Tran, Pippa Newell, Thomas Duhen

Cancer Immunology Research Jun 2021, 9 (6) 602-611; DOI: 10.1158/2326-6066.CIR-20-1024
A DNA-Launched Nanoparticle Vaccine Elicits CD8⁺ T-cell Immunity to Promote In Vivo Tumor Control
Ziyang Xu, Neethu Chokkalingam, Edgar Tello-Ruiz, Megan C. Wise, Mamadou A. Bah, Susanne Walker, Nicholas J. Tursi, Paul D. Fisher, Katherine Schultheis, Kate E. Broderick, Laurent Humeau, Daniel W. Kulp, David B. Weiner

Cancer Immunology Research Nov 2020, 8 (11) 1354-1364; DOI: 10.1158/2326-6066.CIR-20-0061
Activation of CD8⁺ T Cells Contributes to Antitumor Effects of CDK4/6 Inhibitors plus MEK Inhibitors
Jessica L.F. Teh, Dan A. Erkes, Phil F. Cheng, Manoela Tiago, Nicole A. Wilski, Conroy O. Field, Inna Chervoneva, Mitch P. Levesque, Xiaowei Xu, Reinhard Dummer, Andrew E. Aplin

Cancer Immunology Research Sep 2020, 8 (9) 1114-1121; DOI: 10.1158/2326-6066.CIR-19-0743
Remodeling Translation Primes CD8⁺ T-cell Antitumor Immunity
Katie E. Hurst, Kiley A. Lawrence, Rob A. Robino, Lauren E. Ball, Dongjun Chung, Jessica E. Thaxton

Cancer Immunology Research May 2020, 8 (5) 587-595; DOI: 10.1158/2326-6066.CIR-19-0516
Inhibition of the SRC Kinase HCK Impairs STAT3-Dependent Gastric Tumor Growth in Mice
Ashleigh R. Poh, Amy R. Dwyer, Moritz F. Eissmann, Ashwini L. Chand, David Baloyan, Louis Boon, Michael W. Murrey, Lachlan Whitehead, Megan O'Brien, Clifford A. Lowell, Tracy L. Putoczki, Fiona J. Pixley, Robert J.J. O'Donoghue, Matthias Ernst

Cancer Immunology Research Apr 2020, 8 (4) 428-435; DOI: 10.1158/2326-6066.CIR-19-0623

Main menu

User menu

Search

More articles from Priority Brief

Pages

Articles

Info for

About Cancer Immunology Research